Successful management of severe hemolytic disease of the fetus and newborn (HDFN) due to anti-Kell. Hrastar E, Bricl I, Premru-Srsen T, Gubensek J, et al. J Perinat Med 2025 Nov 3. doi: 10.1515/jpm-2025-0347.

Read + Share

Amedeo Smart

Independent Medical Education

Hrastar E, Bricl I, Premru-Srsen T, Gubensek J, et al. Successful management of severe hemolytic disease of the fetus and newborn (HDFN) due to anti-Kell. J Perinat Med 2025 Nov 3. doi: 10.1515/jpm-2025-0347.
PMID: 41170822